Dr. Jack West chats with breast cancer specialist & ASCO Annual Meeting Education Committee chair Dr. Tatiana Prowell about how she engages oncologists & patients alike through live teaching, longitudinal mentoring, & social media. (25:03)
Dr. Tatiana Prowell of Johns Hopkins & US FDA speaks with host Dr. Jack West about how she came to focus on breast cancer, her path to working at FDA, & how her clinical practice & research complement her regulatory work & vice versa. (15:50)
Dr. Tatiana Prowell, breast cancer specialist at Johns Hopkins Univ/Sidney Kimmel Cancer Center & the US FDA, traces her meandering path into medicine & discusses the struggle to choose what to say no to when balancing career & personal life commitments. (23:48)
Dr. West questions Dr. Gideon Blumenthal of the FDA about how he and his team there struggle to provide timely access to emerging cancer treatments, while also debating questions of the proper thresholds for efficacy and safety. (20:15)
Dr. Jack West provides a brief summary of key findings & limitations of two new papers just out in JAMA Oncology (Theelen et al & Bauml et al.) that evaluate the potential benefit of preceding immunotherapy with radiation in patients with advanced NSCLC. (18:00)
